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Background: Comparison of survival and quality of life in a mixed ICU population of patients 80 years of age or
older with a matched segment of the general population.
Methods: We retrospectively analyzed survival of ICU patients ≥80 years admitted to the Haukeland University
Hospital in 2000–2012. We prospectively used the EuroQol-5D to compare the health-related quality of life (HRQOL)
between survivors at follow-up and an age- and gender-matched general population. Follow-up was 1–13.8 years.
Results: The included 395 patients (mean age 83.8 years, 61.0 % males) showed an overall survival of 75.9 (ICU),
59.5 (hospital), and 42.0 % 1 year after the ICU. High ICU mortality was predicted by age, mechanical ventilator
support, SAPS II, maximum SOFA, and multitrauma with head injury. High hospital mortality was predicted by an
unplanned surgical admission. One-year mortality was predicted by respiratory failure and isolated head injury. We
found no differences in HRQOL at follow-up between survivors (n = 58) and control subjects (n = 179) or between
admission categories. Of the ICU non-survivors, 63.2 % died within 2 days after ICU admission (n = 60), and 68.3 %
of these had life-sustaining treatment (LST) limitations. LST limitations were applied for 71.3 % (n = 114) of the
hospital non-survivors (ICU 70.5 % (n = 67); post-ICU 72.3 % (n = 47)).
Conclusions: Overall 1-year survival was 42.0 %. Survival rates beyond that were comparable to those of the general
octogenarian population. Among survivors at follow-up, HRQOL was comparable to that of the age- and sex-matched
general population. Patients admitted for planned surgery had better short- and long-term survival rates than those
admitted for medical reasons or unplanned surgery for 3 years after ICU admittance. The majority of the ICU non-survivors
died within 2 days, and most of these had LST limitation decisions.
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In many countries, aged populations may increase by
40–50 % in the coming decades [1–3]. A similar increase
is expected in the proportion of older patients admitted to
intensive care units (ICU). Patients 80 years of age or
older currently constitute between 8.9 and 13.8 % of
large national ICU registries [4–7]. Australia and New
Zealand showed 5.6 % annual increases in the numbers of* Correspondence: finn.andersen@ntnu.no
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provided the original work is properly creditedoctogenarians that entered the ICU [4]; in Denmark, an
18 % increase was observed from 2005 to 2011 [5].
Few recent studies have focused on long-term health-
related quality of life (HRQOL) in aged ICU survivors,
and even fewer have compared octogenarian ICU pa-
tients to an older segment of the general population.
These studies were mainly performed in medical ICUs
and included small sample sizes, due to high short-term
mortality [8, 9]. One- and 2-year mortalities in octoge-
narians are reported to be as high as 72.0 and 79 % [9],
respectively. Thus, it is important to identify factors
among the older population that predict benefit from
ICU treatment, establish prognostic factors for long-
term survival, and elucidate the HRQOL.article distributed under the terms of the Creative Commons Attribution License
hich permits unrestricted use, distribution, and reproduction in any medium,
.
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1. Compare survival and HRQOL between older
patients and age-matched control groups from the
general population;
2. Identify predictors for short- and long-term mortal-
ity among older ICU patients; and
3. Compare survival and HRQOL scores between the
different SAPS II admission categories: admissions
for planned surgery, unplanned surgery, and medical
reasons.
Methods
Haukeland University Hospital is a tertiary university hos-
pital in Bergen, Norway, which serves approximately one
million inhabitants. The general ICU has ten beds (burn,
cardiac surgery, coronary, and neonatal units are separate
units, and are not included in this study). The annual num-
ber of admissions is about 500, and 7–8 % of patients are 80
years of age or older. There were no large changes in prac-
tice or organization of the ICU during the study period be-
sides general development in medicine and intensive care.
Study design
The first part of this study was a retrospective analysis of
patients ≥80 years old, which were admitted to this gen-
eral ICU between the 1st of January 2000 and the 31st of
December 2012. These data were extracted from the dedi-
cated ICU database with daily, prospectively collected
data. Re-admissions, non-Norwegian patients, and admis-
sions with errors in patient ID were excluded. For all in-
cluded patients, we assessed the following:
1. Age and gender;
2. Length of stay (LOS);
3. Ventilator support, invasive (mechanical) and non-
invasive ventilator support;
4. Severity score (simplified acute physiology score II
(SAPS II) [10]) and organ dysfunction (sequential
organ failure assessment score (SOFA) [11]): we
defined severe organ dysfunctions as a SOFA score
of 3 or 4; among daily SOFA scores, only the
maximum was included in the analysis;
5. Comorbidity: we separated comorbidity in four
categories (none, mild, moderate, and severe) based
on the Charlson comorbidity index (CCI) [12];
6. Diagnostic groups: ICU admissions were allocated
into one of thirteen different categories;
7. Short- and long-term survival (long-term defined
as 1 year and longer): the standardized mortality
ratio (SMR) was defined as the observed hospital
mortality divided by the SAPS II estimated
mortality; the SMR was analyzed for all patients
and for each of the SAPS II admission categories;8. Survival at follow-up; and
9. SAPS II admission categories, planned surgery,
unplanned surgery, and medical reasons.
Survival was compared with a segment of the general
population that was 80 years of age or older during 2000–
2013, based on life tables from Statistics Norway.
The second part of the study included a prospective
analysis of HRQOL. Patients alive at follow-up (16th of
January 2014) were compared with a control group of 375
individuals matched for age, sex, and residence, which
were randomly drawn from the National Registry. The
HRQOL was assessed with EuroQol-5D (EQ-5D-3L) [13],
a questionnaire sent by mail to ICU survivors and the
control group at follow-up. EQ-5D has five dimensions,
each with three response options. It also included a visual
analog scale (EQ-VAS; Table 4). A reminder was sent to
the non-responders after 1 month. ICU survivors were
also contacted by phone. Informed consent was given by
persons who answered the questionnaire.
We compared hospital survivors with hospital non-
survivors and also compared the SAPS II admission cat-
egories. Information about end-of-life decision-making
was retrospectively found for hospital non-survivors by
searching through the individual patient files of their
current hospital stay since such information was not en-
tered in the ICU database. We only included statements
which clearly used the terms withholding or withdrawal of
ICU treatment.
The study was approved by the Regional Committee of
Medical and Health Research Ethics in Central Norway
(REC Central, 2013/1113).
Statistics
The length of stay (LOS) and ventilator time are expressed
in terms of medians and quartiles. Significance was tested
with the Mann-Whitney U test/Kruskal-Wallis test. Other
continuous variables are expressed as the mean with stand-
ard deviation (SD) and compared with the t test/analysis of
variance (ANOVA). Qualitative and dichotomous data are
reported as the percent of n, and they were compared with
Pearson’s chi-square test/Fisher’s exact test or with the
Mann-Whitney U test. Three separate Cox proportional
hazard regression analyses were used to determine inde-
pendent predictors of ICU mortality, hospital mortality,
and 1-year mortality. The time factor was defined as the
number of days from ICU admission, ICU discharge, and
hospital discharge, respectively. All variables with a p value
of <0.2 in a primary univariate analysis were included in the
multivariate model, except for admission categories; admis-
sion categories were included even when the p value was
>0.2 in the univariate analysis. ICU mortality was analyzed
separately. Only ICU survivors were included in the ana-
lysis of hospital mortality. Only hospital survivors were
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iables were then tested separately in the models, and in-
cluded if they were significant. Adjusted hazard ratios (HR)
were calculated with 95 % confidence intervals (95 % CI).
Kaplan-Meier curves were constructed from the three SAPS
II admission categories. Another Kaplan-Meier curve was
constructed to compare all patients to the general octogen-
arian population in Norway. An adjusted mortality rate was
calculated by dividing the observed mortality rate by the ex-
pected mortality rate from an age- and gender-matched
population. The adjusted mortality rate was calculated be-
tween 1 and 8 years after ICU admission. Patients who were
alive at follow-up were censored. All statistical analyses were
performed with SPSS 21.0 (SPSS Inc., Chicago, IL, USA). P
values <0.05 were considered statistically significant.Alive at follow-up, n=73 (18.5%)
Included patient stays, n=419
Die
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Died after inclusion
Excluded patients
Patients for analysis, n=395 
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Fig. 1 Data collection processResults
From 2000 to 2012, 402 patients ≥80 years were admitted
to our ICU, with a total of 419 ICU stays. Re-admissions
(during the same hospital stay (n = 10) and during another
later hospital stay (n = 7)), non-Norwegian patients (n =
4), and admissions with errors in patient ID (n = 3) were
omitted from the analysis. Thus, 395 patients were in-
cluded in the current study (Fig. 1).
Patient characteristics
Age and gender
At ICU admittance, the mean age was 83.8 years (range
80–101; median 83.1) and 61.0 % were males (Table 1).
Males had longer median ICU-LOS (2.1 vs. 1.5 days, p =
0.006), a higher mean maximum SOFA score (8.3 vs. 7.0,Died in ICU, n=95
d during hospital stay, n=160 (49.7%)
ed after hospital discharge, n=162 (50.3%)
r in patient ID, n=3 
ign patients, n= 4
, n=322 (81.5%)
, n=24
missions during same hospital stay, n= 10
Unable to answer, n=1
Questionnaires without identity, n=2
Missing answers, n=12
missions during another later hospital stay, n=7
Table 1 Differences in characteristics between hospital survivors and hospital non-survivors
Total (n = 395) Hospital survivors (n = 235) Hospital non-survivors (n = 160) p value
Age, mean ± SD 83.8 ± 2.9 83.5 ± 2.9 84.1 ± 2.8 0.049a
Male, % 61.0 60.9 61.3 0.511b
Length of stay (LOS), median (IQR)
ICU-LOS 1.8 (0.9–3.9) 1.9 (1.0–4.3) 1.7 (0.8–3.2) 0.097c
Hospital LOS 11.3 (4.0–19.3) 14.2 (7.6–25.1) 5.5 (1.9–12.8) <0.001c
Ventilator support
Mechanical ventilator support, % (n) 61.3 (242) 51.9 (122) 75.0 (120) <0.001b
Mechanical ventilator support time, median (IQR) 1.2 (0.5–3.3) 1.3 (0.5–3.8) 1.0 (0.4–3.0) 0.235c
Non-invasive ventilator support, % (n) 33.2 (131) 35.8 (84) 29.6 (47) 0.344b
Non-invasive ventilator support time, median (IQR) 1.5 (0.5–2.8) 1.6 (0.5–3.2) 1.3 (0.4–2.5) 0.164c
Severity score, mean ± SD
SAPS II 44.3 ± 15.0 (n = 390) 40.6 ± 12.9 (n = 230) 49.5 ± 16.3 (n = 160) <0.001a
Max. SOFA 7.8 ± 3.8 (n = 389) 6.7 ± 3.3 (n = 229) 9.5 ± 3.8 (n = 160) <0.001a
Comorbidity
Charlson comorbidity index, mean ± SD 2.6 ± 1.9 (n = 390) 2.7 ± 1.8 (n = 234) 2.5 ± 1.9 (n = 156) 0.389a
Charlson comorbidity index (CCI) categories, % (n) 0.602b
None (CCI 0) 12.3 (48) 11.1 (26) 14.1 (22)
Mild (CCI 1–2) 40.8 (159) 39.3 (92) 42.9 (67)
Moderate (CCI 3–4) 32.3 (126) 34.2 (80) 29.5 (46)
Severe (CCI ≥5) 14.6 (57) 15.4 (36) 13.5 (21)
Severe organ dysfunction, % (n)
Respiration 66.3 (262) 62.6 (147) 71.9 (115) 0.034b
Circulation 47.1 (186) 38.7 (91) 59.4 (95) <0.001b
Renal 28.1 (111) 20.9 (49) 38.8 (62) <0.001b
CNS 26.1 (103) 18.7 (44) 36.9 (59) <0.001b
Coagulation 9.9 (39) 9.8 (23) 10.0 (16) 0.537b
Liver 1.3 (5) 0.9 (2) 1.9 (3) 0.399d
Admission categories, % (n) <0.001b
Planned surgery 12.7 (50) 17.9 (42) 5.0 (8)
Unplanned surgery 53.9 (213) 49.8 (117) 60.0 (96)
Medical reasons 33.4 (132) 32.3 (76) 35.0 (56)
Diagnostic groups, % (n)
Respiratory failure 28.1 (111) 31.1 (73) 23.8 (38) 0.112b
Circulatory failure 8.1 (32) 7.7 (18) 8.8 (14) 0.697b
Combined respiratory and circulatory failure 10.4 (41) 8.9 (21) 12.5 (20) 0.254b
Neurologic failure 10.1 (40) 9.4 (22) 11.3 (18) 0.541b
Isolated head injury 2.5 (10) 1.7 (4) 3.8 (6) 0.328d
Sepsis 8.9 (35) 7.2 (17) 11.3 (18) 0.168b
Gastroenterological failure 4.8 (19) 4.7 (11) 5.0 (8) 0.884b
Multiple organ failure 5.6 (22) 3.0 (7) 9.4 (15) 0.007b
Multitrauma without head injury 3.8 (15) 5.1 (12) 1.9 (3) 0.099b
Multitrauma with head injury 2.3 (9) 1.7 (4) 3.1 (5) 0.495d
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Table 1 Differences in characteristics between hospital survivors and hospital non-survivors (Continued)
Planned surgery 3.3 (13) 5.5 (13) 0.0 (0) 0.002b
Acute operation 6.6 (26) 7.2 (17) 5.6 (9) 0.527b
Unspecified 5.6 (22) 6.8 (16) 3.8 (6) 0.193b
IQR interquartile range, SD standard deviation, CI confidence interval, ICU intensive care unit, SAPS II simplified acute physiology score II, SOFA sequential organ
failure assessment, CCI Charlson comorbidity index
aIndependent t test
bPearson’s chi-square
cMann-Whitney U test
dFisher’s exact test
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(52.3 vs. 39.0 %, p = 0.010) than females.
Length of stay
The overall median ICU-LOS and hospital-LOS were 1.8
and 11.3 days, respectively. The median LOS for ICU
non-survivors was 1.3 days (see Table 1). Among all pa-
tients, 26.8 % stayed less than 1 day in the ICU.
Ventilator support
Of 395 patients, 61.3 % received mechanical ventilator
support for a median time of 1.2 days. Of the hospital
non-survivors, 75.0 % (n = 120) received mechanical
ventilator support (Table 1). A fraction of 69.2 % (n =
83) of these 120 patients had life-sustaining treatment
limitation decisions.
Severity scores and severe organ dysfunction
Overall, the mean SAPS II and mean maximal SOFA
scores were 44.3 and 7.8, respectively. Hospital non-
survivors had a mean SAPS II of 49.5 and a mean max-
imal SOFA score of 9.5 (Table 1). All patients with max-
imal SOFA scores ≥17 died in the ICU; all those with
scores ≥16 died during the hospital stay.
Comorbidity
Overall mean Charlson comorbidity index was 2.6. Pa-
tients admitted for planned surgery showed the highest
index score among the admission categories (3.2). Only
12.3 % of the patients had no preexisting comorbidity
(see Table 1 and 2).
Diagnostic groups
The most frequent cause for ICU admission was respira-
tory failure (28 %). Respiratory failure was most com-
mon in the planned surgery group (44 %; Table 2).
Survival and predictors of mortality
Short-term survival
The overall ICU and hospital survival were 75.9 and
59.5 %, respectively. Of the ICU non-survivors, 63.2 %
died within 2 days after ICU admission (n = 60), and
68.3 % of these patients had life-sustaining treatment
(LST) limitations ((n = 41); withholding 60.0 % andwithdrawal 51.7 %). The SMR was 1.06, with large differ-
ences between the planned surgery (0.55) and unplanned
surgery (1.15) groups. For survival at 30, 90, and 180
days, see Table 2.
Predictors of high ICU mortality were age, mechanical
ventilator support, SAPS II, maximum SOFA, and multi-
trauma with head injury. Increased hospital mortality
was predicted by an unplanned surgical admission
(Table 3).Long-term survival (1 year and longer)
The overall 1- and 2-year survival rates were 42.0 and
36.6 %, respectively. After 5 years, 22.2 % of all patients
remained alive. A comparison between patients (n =
395) and the general population greater than 80 years
old in Norway (n = 426 773) showed excess mortality
among patients in the first year, with an adjusted mortal-
ity rate of 6.35 (95 % CI 5.58–7.23). After the first year,
the survival rates were similar between groups; patients
had an adjusted mortality rate during the second year of
1.34 (95 % CI 0.86–2.07; Fig. 2). Among patients alive
after 1 year, the mean survival time, starting from the 1-
year point, was 5.1 years.
Respiratory failure and isolated head injury were inde-
pendent predictors of 1-year mortality (Table 3).Survival at follow-up
At follow-up (January 2014), 322 (81.5 %) patients had
died, including 160 during the hospital stay and 162
after hospital discharge. Seventy-three patients (18.5 %)
survived, with a mean age of 86.9 years at follow-up.
The median time from hospital discharge to follow-up
was 3.3 years (range 1–13.8 years; Fig. 1). The survivors
at follow-up (n = 73) had, compared to hospital survi-
vors not alive at follow-up (n = 162), similar ICU-LOS
(1.9 vs. 1.8 days; p = 0.465), fraction of ventilator sup-
port (52.1 vs. 51.9 %; p = 0.977), severity of illness (SAPS
II 43.2 vs. 39.4, p = 0.658; max. SOFA 6.5 vs. 6.7, p =
0.313), and comorbidity (Charlson comorbidity index 2.4
vs. 2.8, p = 0.156; Additional file 1: Table S1). However,
hospital survivors not alive at follow-up had a lower me-
dian survival after hospital discharge (3.1 years), com-
pared to the follow-up of 3.4 years in survivors.
Table 2 Characteristics of SAPS II admission categories
Planned surgery
(n = 50)
Unplanned surgery
(n = 213)
Medical reasons
(n = 132)
Total (n = 395) p value
Age, mean ± SD 83.5 ± 2.7 84.0 ± 2.7 83.5 ± 3.2 83.8 ± 2.9 0.217a
Male, % 64.0 60.6 60.6 61.0 0.889b
Length of stay (LOS), median (IQR)
ICU-LOS 2.0 (1.0–4.4) 2.2 (1.0–5.0) 1.2 (0.6–2.6) 1.8 (0.9–3.9) <0.001b
Hospital LOS 15.1 (10.2–26.2) 12.9 (4.3–20.6) 6.5 (2.0–14.3) 11.3 (4.0–19.3) <0.001b
Ventilator support
Mechanical ventilator support, % (n) 48.0 (24) 69.5 (148) 53.0 (70) 61.3 (242) 0.001b
Mechanical ventilator support time,
median (IQR)
1.1 (0.4–3.7) 1.3 (0.5–3.8) 0.9 (0.3–2.0) 1.2 (0.5–3.3) 0.050b
Non-invasive ventilator support, % (n) 44.0 (22) 33.8 (72) 28.0 (37) 29.6 (47) 0.119b
Non-invasive ventilator support time, median (IQR) 1.2 (0.5–2.6) 2.0 (0.6–3.0) 1.0 (0.3–2.0) 1.3 (0.4–2.5) 0.056b
Severity score, mean ± SD
SAPS II 39.0 ± 13.2
(n = 47)
44.6 ± 14.8
(n = 212)
45.6 ± 15.6
(n = 131)
44.3 ± 15.0
(n = 390)
0.030a
Max. SOFA 6.3 ± 4.1 (n = 47) 8.3 ± 3.6 (n = 212) 7.5 ± 3.8 (n = 130) 7.8 ± 3.8 (n = 389) 0.002a
Comorbidity
Charlson comorbidity index, mean ± SD 3.2 ± 1.8 (n = 50) 2.5 ± 2.0 (n = 209) 2.5 ± 1.7 (n = 131) 2.6 ± 1.9 (n = 390) 0.050a
Charlson comorbidity index (CCI) categories, % (n)
None (CCI 0) 4.0 (2) 13.4 (28) 13.7 (18) 12.3 (48) 0.159b
Mild (CCI 1–2) 34.0 (17) 43.1 (90) 39.7 (52) 40.8 (159) 0.436b
Moderate (CCI 3–4) 46.0 (23) 26.3 (55) 36.6 (48) 32.3 (126) 0.009b
Severe (CCI ≥5) 16.0 (8) 17.2 (36) 9.9 (13) 14.6 (57) 0.163b
Severe organ dysfunction, % (n)
Respiration 68.0 (34) 71.8 (153) 56.8 (75) 66.3 (262) 0.016b
Circulation 38.0 (19) 53.1 (113) 40.9 (54) 47.1 (186) 0.035b
Renal 30.0 (15) 28.6 (61) 26.5 (35) 28.1 (111) 0.868b
CNS 20.0 (10) 23.5 (50) 32.6 (43) 26.1 (103) 0.100b
Coagulation 16.0 (8) 8.5 (18) 9.8 (13) 9.9 (39) 0.273b
Liver 2.0 (1) 0.0 (0) 3.0 (4) 1.3 (5) 0.034d
Survival, % (n)
ICU 90.0 (45) 74.2 (158) 73.5 (97) 75.9 (300) 0.045b
Hospital 84.0 (42) 54.9 (117) 57.6 (76) 59.5 (235) 0.001b
30 days 86.0 (43) 51.2 (109) 54.5 (72) 56.7 (224) <0.001b
90 days 82.0 (41) 44.6 (95) 50.8 (67) 51.4 (203) <0.001b
180 days 74.0 (37) 40.4 (86) 47.7 (63) 47.1 (186) <0.001b
1 year 68.0 (34) 37.1 (79) 40.2 (53) 42.0 (166) <0.001b
2 years 59.9 (28) 33.1 (64) 33.6 (39) 36.6 (130) 0.001b
3 years 48.4 (15) 27.8 (50) 29.9 (32) 31.2 (96) 0.088b
5 years 32.8 (7) 18.6 (28) 23.7 (22) 22.2 (55) 0.290b
Diagnostic groups, % (n)
Respiratory failure 44.0 (22) 24.4 (52) 28.0 (37) 28.1 (111) 0.021b
Circulatory failure 8.0 (4) 8.5 (18) 7.6 (10) 8.1 (32) 0.959b
Combined respiratory and circulatory failure 8.0 (4) 12.7 (27) 7.6 (10) 10.4 (41) 0.270b
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Table 2 Characteristics of SAPS II admission categories (Continued)
Neurologic failure 2.0 (1) 7.0 (15) 18.2 (24) 10.1 (40) <0.001b
Isolated head injury 0.0 (0) 1.9 (4) 4.5 (6) 2.5 (10) 0.165d
Sepsis 4.0 (2) 8.9 (19) 10.6 (14) 8.9 (35) 0.308d
Gastroenterological failure 0 (0) 5.6 (12) 5.3 (7) 4.8 (19) 0.276d
Multiple organ failure 4.0 (2) 7.5 (16) 3.0 (4) 5.6 (22) 0.205d
Multitrauma without head injury 0.0 (0) 5.6 (12) 2.3 (3) 3.8 (15) 0.107d
Multitrauma with head injury 0.0 (0) 2.3 (5) 3.0 (4) 2.3 (9) 0.638d
Planned surgery 18.0 (9) 1.4 (3) 0.8 (1) 3.3 (13) <0.001d
Acute operation 2.0 (1) 10.3 (22) 2.3 (3) 6.6 (26) 0.004d
Unspecified 10.0 (5) 3.8 (8) 6.8 (9) 5.6 (22) 0.150d
SMR (95 % CI) 0.55 (0.28–1.11)
(n = 47)
1.15 (0.94–1.40)
(n = 212)
1.05 (0.81–1.37)
(n = 131)
1.06 (0.90–1.23)
(n = 390)
Survival times were derived from the life table method
IQR interquartile range, SD standard deviation, CI confidence interval, ICU intensive care unit, SAPS II simplified acute physiology score II, SOFA sequential organ
failure assessment, CCI Charlson comorbidity index, SMR standardized mortality ratio
aWith ANOVA (analysis of variance)
bPearson’s chi-square test
cWith Kruskal-Wallis test
dFisher’s exact test
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Patients admitted for planned surgery had significantly
higher survival rates than those admitted for medical
reasons and unplanned surgery up to 3 years after ICU
admittance (Table 2). The median survival times were
33.4 months (95 % CI 21.2–45.6) for planned surgery,
1.2 months (95 % CI 0.0–2.7) for unplanned surgery,
and 2.7 months (95 % CI 0.0–9.1) for medical admis-
sions (Fig. 3).Health-related quality of life
The EQ-5D questionnaire was sent to the 73 patients who
were alive at follow-up. The response rate was 83.6 % (n =
61), but one questionnaire was incomplete, and two ques-
tionnaires had no patient identity. Fourteen patients
responded to the questionnaire by telephone. The response
rate in the control group was 47.7 % (179/375), constituting
2.5 controls per survivor at follow-up. HRQOL was similar
between patients and the general population and among the
admission categories (Table 4).Life-sustaining treatment limitation in hospital non-
survivors
Of the ICU non-survivors, 70.5 % (n = 67) had treatment-
limitation decisions; withholding 68.4 % (n = 65) and with-
drawal 51.6 % (n = 49). The majority of these LST limita-
tion decisions were taken within the first 2 days after ICU
admission (61.2 % (n = 41)). Post ICU 72.3 % (n = 47) of
the hospital non-survivors had treatment-limitation deci-
sions; withholding 72.3 % (n = 47) and withdrawal 32.3 %
(n = 21). We lack information on LST decisions in six
ICU non-survivors and two ICU survivors.Discussion
This study establishes three major results. First, patients
who survived the first year after ICU admittance showed
long-term survival rates similar to those of the normal
Norwegian octogenarian population. The HRQOL of
long-time survivors was comparable to that of an age- and
sex-matched general population group. Second, the
planned surgery group exhibited higher survival rates than
the medical and unplanned surgery groups up to 3 years
after ICU admittance. However, at follow-up, HRQOL did
not differ among these three groups. Third, high ICU
mortality was predicted by age, mechanical ventilator sup-
port, SAPS II, maximum SOFA score, and multitrauma
with head injury. High hospital mortality was predicted by
an unplanned surgical admission. Respiratory failure and
isolated head injury were independent predictors of 1-year
mortality. The majority of the ICU non-survivors died
within 2 days, where most of these had life-sustaining
treatment (LST) limitations. Almost three quarters of the
hospital non-survivors had treatment-limitation decisions.
Our finding of age as an independent predictor of ICU
mortality contrasts with several previous studies [14, 15].
Conflicting results about the impact of age on outcome
for older patients in the ICU may be explained by varia-
tions in adjustments for severity and comorbidities
among different studies. Moreover, in some institutions,
older individuals may have been denied ICU admission,
based on advanced age [16]. In addition, treatment is
often withheld for older ICU patients with severe co-
morbidity [17]. In our study, advanced age may also have
influenced preferences in decision-making among pa-
tients, relatives, or caregivers. The influence of age on
mortality must be adjusted for severity of illness.
Table 3 Predictors of mortality in the ICU, in hospital, and at 1 year after admission
ICU mortality
(n = 389)
Hospital mortality for
ICU survivors (n = 294)
1-year mortality for hospital
survivors (n = 230)
Adjusted HR (95 % CI) Adjusted HR (95 % CI) Adjusted HR (95 % CI)
Age, years 1.10 (1.03–1.18)a
Male
Ventilator support
Mechanical ventilator support 1.99 (1.10–3.60)a 1.40 (0.81–2.43)
Non-invasive ventilator support 0.87 (0.51–1.49)
Severity score, mean
SAPS II 1.03 (1.01–1.04)a 1.01 (0.99–1.03) 1.01 (0.99–1.03)
Max. SOFA 1.20 (1.10–1.31)a 1.03 (0.95–1.12)
Comorbidity
None (CCI 0) 1.00 1.00
Mild (CCI 1–2) 0.68 (0.35–1.30) 1.02 (0.43–2.46)
Moderate (CCI 3–4) 0.53 (0.25–1.11) 1.06 (0.42–2.65)
Severe (CCI ≥ 5) 0.53 (0.23–1.25) 2.09 (0.99–5.39)
Severe organ dysfunction
Respiration 1.05 (0.55–1.97)
Circulation 0.76 (0.39–1.48)
Renal 1.50 (0.88–2.54)
CNS 1.19 (0.71–1.99)
Coagulation
Liver
Admission categories
Planned surgery 1.00 1.00 1.00
Unplanned surgery 1.40 (0.54–3.65) 3.46 (1.06–11.24)a 2.02 (0.88–4.64)
Medical reasons 2.11 (0.80–5.58) 3.17 (0.94–10.76) 1.97 (0.83–4.70)
Diagnostic groups
Respiratory failure 1.03 (0.55–1.90) 1.86 (1.13–3.07)a
Circulatory failure
Combined respiratory and circulatory failure
Neurologic failure 1.67 (0.86–3.25)
Isolated head injury 1.56 (0.58–4.18) 9.12 (2.44–34.14)a
Sepsis 1.20 (0.63–2.69)
Gastroenterological failure
Multiple organ failure 1.27 (0.60–2.69) 1.67 (0.64–4.31)
Multitrauma without head injury
Multitrauma with head injury 2.99 (1.04–8.60)a
Planned surgery
Acute operation
Unspecified
ICU intensive care unit, SAPS II simplified acute physiology score II, SOFA sequential organ failure assessment, HR hazard ratio, CI confidence interval, CCI Charlson
comorbidity index
aSignificant differences
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All patients (n=395)
+      Censored patients
----- Norwegian octogenarian population (n=426 773)
Fig. 2 Kaplan-Meier survival curve for all patients (solid blue line) compared to the Norwegian octogenarian population (dashed black line) in 2000–2013
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countries [6, 7, 18]. One explanation can be the low
availability of ICU beds compared to many other European
countries [3, 19]. Also, octogenarians are in general found
to have shorter ICU stays than younger patients [6, 20, 21].
This is probably reflected in our study. The overall median
ICU-LOS was 1.8 days, which was 3.2–4.2 days shorter
than that reported in recent French studies [8, 9]. Also, our
ICU and hospital mortality rates were lower than reported
in those studies. These findings might be explained byFig. 3 Kaplan-Meier survival curves of SAPS II admission categoriesdifferences in “case-mix” within the SAPS II admission cat-
egories, where the French studies included mostly medical
cases. However, our medical group had significantly shorter
ICU stays (median 1.2 days) than the unplanned surgery
group. This finding could not be explained by differences in
mortalities or SAPS II scores. Even though ICU-LOS is
short in our study, the mean SAPS II scores and mechan-
ical ventilator support rates are comparable to other octo-
genarian cohort studies [8, 9, 14, 21–23]. In general, our
survivors had longer ICU stays than non-survivors, due toSAPS II admission categories
Unplanned surgery (n=213)
+       Unplanned surgery- censored
------- Medical reasons (n=132) 
+       Medical reasons- censored 
- - - Planned surgery (n=50)
+       Planned surgery- censored
Table 4 Comparison of frequency distributions (profiles) of the EQ-5D-3L for patient and control groups
Variable Total patients (n = 58) Control group (n = 179) p value
Age, years, mean ± SD 87.4 ± 4.0 86.7 ± 4.4 0.265a
Male, % (n) 69.0 (40) 66.5 (119) 0.726b
Mobility, % (n) 0.504c
No problem 41.4 (24) 43.6 (78)
Some problems 51.7 (30) 54.7 (98)
Confined to bed 6.9 (4) 1.7 (3)
Self-care, % (n) 0.957c
No problem 75.9 (44) 74.9 (134)
Some problems 15.5 (9) 21.8 (39)
Unable to 8.6 (5) 3.4 (6)
Usual activities, % (n) 0.237c
No problem 43.1 (25) 49.7 (89)
Some problems 41.4 (24) 41.3 (74)
Unable to 15.5 (9) 8.9 (16)
Pain and discomfort, % (n) 0.229c
None 43.1 (25) 34.6 (62)
Moderate 51.7 (30) 58.1 (104)
Extreme 5.2 (3) 7.3 (13)
Anxiety and depression, % (n) 0.258c
None 77.6 (45) 69.8 (125)
Moderate 20.7 (12) 27.9 (50)
Extreme 1.7 (1) 2.2 (4)
EQ index, mean ± SD 0.71 ± 0.28 0.73 ± 0.23 0.924c
EQ VAS, mean ± SD 63.9 ± 20.3 (n = 53) 67.7 ± 22.0 (n = 170) 0.219c
SD standard deviation, EQ EuroQol, VAS visual analog scale (range 0–100)
aIndependent t test
bPearson’s chi-square
cMann-Whitney U test
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The large proportion of LST limitations among ICU non-
survivors during the first 2 days after ICU admission may
contribute to the short length of stay. Our data could indi-
cate that ICU physicians limit the intensity of life-
sustaining treatment if there is no improvement in the con-
dition of the octogenarian patient within the first 2 days
after ICU admission. Although we lack data on triage deci-
sions prior to ICU admission, we might speculate that a
more thorough pre-ICU triage process could have de-
creased the rather high fraction of LST limitation decisions
by rejecting patients who probably would not benefit from
ICU treatment.
After the first year, we found our ICU patients to have
survival rates similar to those of the general octogenarian
population. Interestingly, Roch et al. found a similar trend
after 2 years [9]. The low 1-year survival rate may indicate
that many aged patients did not benefit from ICU treat-
ment. Therefore, we need better predictors to determine
which patients are likely to gain long-term benefit fromICU treatment. Several studies have reported prognostic
factors for short- and long-term mortality among older in-
dividuals [14, 17, 24]. In general, short-term mortality is
most frequently predicted by severity scores and the num-
ber of organ failures [17]. Commonly used prognostic
models for aged patients in the ICU lack calibration.
Nevertheless, our study showed that severity scores were
good predictors for ICU mortality, in addition to age,
mechanical ventilator support, and multitrauma with head
injury. One study developed a prognostic model for pre-
dicting in-hospital mortality in older patients in the ICU,
and found low Glacow coma scale (GCS) scores to be
strongly related to short-term mortality [24]. Several other
studies have reported that brain injury is associated with
poor outcomes in older patients [25, 26]. Comorbidity is
also found to be a predictor of long-term survival in some
octogenarian ICU studies [9, 14]. However, these studies
used the McCabe classification, where comorbidity is based
on the presence of underlying fatal diseases. In our study,
we found no association between long-term mortality and
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supported in other studies [5, 27], also using Charlson co-
morbidity index. The regression analysis of ICU mortality
showed decreasing hazard of death with increasing comor-
bidity. This was probably mainly due to admission of pa-
tients with no comorbidity who suffered severe trauma and
bleeding events, with high mortality. We might speculate
that the admission policy of these patients was more liberal
due to lack of comorbidity, even if the prospects of survival
was low, compared to patients with higher comorbidity. In
our opinion, comorbidity is not a very useful predictor for
ICU mortality in general nor for the elderly population.
To our knowledge, this study is the first to report
HRQOL in older patients over a 13-year post-ICU follow-
up. We found similar HRQOLs in ICU survivors and the
general Norwegian octogenarian population at follow-up.
Other recent studies on HRQOL in older ICU survivors
have reported impaired physical function [9, 28]. De Rooij
et al. found that patients had more problems with usual
activities and lower mean EQ VAS scores than the general
British population [29]. In contrast, Tabah et al. reported a
similar HRQOL, or better in some domains, compared to
a matched general population [8]. Good HRQOL percep-
tions, despite physical impairment, could be due to lower
expectations of life after critical illness. However, HRQOL
evaluations may be prone to selection bias, because re-
sponders may represent healthier patients. Our study re-
vealed that non-responders and responders had similar
severity scores and similar fractions of severe organ fail-
ures. But non-responders were evaluated at slightly longer
times after hospital discharge (median 4.6 vs. 3.3 years;
p = 0.350). Patients alive after 1 year had a mean further
survival time of 5.1 years. Furthermore, survivors at
follow-up had longer time to follow-up compared to the
median survival in hospital survivors not alive at follow-
up. Nevertheless, these groups were otherwise compar-
able, and we can speculate that hospital survivors no
longer alive had about the same HRQOL as survivors at
follow-up, at least for much of the time left (Additional
file 1: Table S1).
Very few studies have reported outcomes for aged pa-
tients in different SAPS II admission categories. De Rooij
et al. reported higher short- and long-term survival in pa-
tients admitted for planned surgery compared to those ad-
mitted for medical reasons and unplanned surgery, with a
mean follow-up of 3.6 years [22]. Our results supported
that finding, but only up to 3 years after ICU admittance.
Thereafter, long-term survival was similar among the
groups. We also found that an unplanned surgery admis-
sion could predict high hospital mortality in ICU survivors.
Limitations
This study has several limitations. First, it was partly a retro-
spective study and clinical data were confined to thoseregistered in the ICU database. Thus, we had no informa-
tion about triage decisions made before ICU admission.
Variability in these decisions may influence the results [30–
32]. Second, the long inclusion period could contain
changes in admission policy and medical practice. However,
the catchment area and basic functions of the hospital
remained the same during the study period, with a slowly
growing population and all medical services except organ
transplant surgery offered. There were no large changes in
practice or organizational changes in the ICU during the
study period. Third, due to our single-center study design,
the group sizes were relatively small. In particular, the num-
ber of patients for HRQOL assessment was limited (n =
73); this is common in single-center studies of aged ICU
populations. Furthermore, the HRQOLs of different groups
were evaluated at different follow-up times. Nevertheless,
every patient was followed-up after at least 1 year, the rec-
ommended minimum [33]. Furthermore, the high response
rate for the EQ-5D questionnaire (n = 58, 79.5 %) provided
valuable HRQOL information among older, long-term ICU
survivors in Norway, particularly compared to the age- and
gender-matched control group. We evaluated HRQOL once
in each patient; thus, we did not study changes in HRQOL
over time. Ideally, a baseline measurement should be made
before the ICU stay. Finally, we had no information on living
status or cognitive functions.
Conclusions
One-year survival was 42.0 %, with further survival com-
parable to the general octogenarian population. HRQOL
in survivors was comparable with an age- and sex-
matched general population, with a follow-up of 1–13.8
years. Up to 3 years after ICU admittance, patients admit-
ted for planned surgery had better short- and long-term
outcomes than those admitted for medical reasons and
unplanned surgery. The majority of the ICU non-
survivors died within 2 days, and most of these had
life-sustaining treatment (LST) limitations. Almost three
quarters of the hospital non-survivors had treatment-
limitation decisions. Our results indicate that older ICU
patients have poor short-term outcomes due to high mor-
talities, but good long-term outcomes in those who sur-
vive beyond 1 year. Predictors identified in this study may
facilitate triage decisions in older patients regarding ICU
treatment. Future research should focus on improving
prognostic models for aged patients.
Key messages
 One-year survival was 42.0 %; thereafter, survival
was comparable to that of the general octogenarian
population.
 HRQOL in our survivors at follow-up (n = 58)
was comparable with an age- and gender-matched
Andersen et al. Annals of Intensive Care  (2015) 5:13 Page 12 of 13general population (n = 179), for a follow-up of
1–13.8 years.
 Patients admitted for planned surgery had better
short- and long-term survival rates than those ad-
mitted for medical reasons or unplanned surgeries
for three years after ICU admittance.
 The majority of the ICU non-survivors died within 2
days (63.2 %), and most of these had life-sustaining
treatment (LST) limitations (68.3 %).
Additional file
Additional file 1: Table S1. Differences in characteristics between hospital
survivors not alive at follow-up (n = 162) and survivors at follow-up (n = 73).
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